: Speaker List

Speaker View

Below is a listing of all sessions the speaker is scheduled to present.

Pat Poisson

United Therapeutics

Speaker Bio

Patrick Poisson holds the position of VP, Manufacturing Fill/Finish with United Therapeutics, a rapidly growing pharmaceutical company based in Silver Spring, MD, where he is responsible for overseeing the company's sterile manufacturing operation. Prior to joining United Therapeutics Mr. Poisson was employed by RxElite, Cardinal Health and Genentech where he held various positions of escalating responsibility in sterile manufacturing and product development. In addition to his 19 years of professional experience, Mr. Poisson has been a frequent technical speaker at industry conferences, is the co-author of multiple aseptic processing research articles, and is a named inventor in three international patents. Mr. Poisson holds a B.Sc. from Michigan State University.

Have a Question?

You can pose a question to the speaker by clicking on the "Suggest a Question" icon at the end of the session title. Appropriate questions will be answered during the session as time permits (not all questions will be answered).
Tuesday, March 29, 2011
Conference Program
Suggest A Question for this Session
Aseptic Processing Facility Design and Machine Integration: A Unique Case Study
Room: 1E14 ~ 2:00 pm - 3:30 pm (Tuesday, March 29, 2011)
The manufacturing of aseptic liquid and lyophilized products presented unique challenges for United Therapeutics and the need for a flexible, multi-purpose facility capable of manufacturing aseptic products in multiple formats was critical. This case study focuses on the innovative design considerations, flexibility, equipment integration and implementation of Barrier Isolation and Blow-Fill-Seal (BFS) technologies for the production of sterile liquid drug products in either glass vials (injectables) or BFS ampoules (inhalation) for worldwide distribution.
Beginning with architectural considerations and followed by technology advances, the speakers will demonstrate substantial space limitations, cost savings and an in-depth look at the many unique, first-time equipment configurations within the 34,000sf facility. This includes the custom designed total single-use disposable technology on the barrier isolator vial line. They will present how strategic and project execution planning ensured the new facility was compliant, addressed the needs for aseptic production, introduced new, advanced aseptic technologies, mitigated risk of cross contamination and assured the microbiological integrity of the finished drug product. Additional innovative design approaches include critical utility accessibility and the latest optimization methodologies for process and operational efficiency.
Sterling Kline - RA, Integrated Project Services (IPS)
Pat Poisson, United Therapeutics
Reed Exhibitions
  • Pharmaceuticals
  • Biologics
  • Generics
  • Contract Services
ConferencePath System © 2004 - 2015 ConferencePath & MasseyMedia. All Rights Reserved.